RESEARCH TRIANGLE PARK, N.C., AgBiome announced it has raised $116 million in an oversubscribed Series D round of funding.
AgBiome, the leader in developing innovative products from the Earth's microbial communities, announced it has raised $116 million in an oversubscribed Series D round of funding, co-led by Blue Horizon and Novalis LifeSciences and that included multiple new and existing investors. The company will use the capital to expand more rapidly its product portfolio, scale its scientific and commercial teams, and continue to build its global presence and partnerships.
AgBiome¬® partners with the microbial world to improve our planet. AgBiome discovers and develops innovative biological and trait products for crop protection. The proprietary GENESIS discovery platform efficiently captures diverse, unique microbes for agriculturally relevant applications, and screens them with industry-best assays for insect, disease, and nematode control. Through its commercial subsidiaries, AgBiome develops and sells proprietary crop protection solutions. The first of these, Howler¬®, is a revolutionary fungicide for disease control in a broad variety of crops.
(c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about